Baker Brothers Advisors - SILVERBACK THERAPEUTICS INC ownership

SILVERBACK THERAPEUTICS INC's ticker is SBTX and the CUSIP is 82835W108. A total of 90 filers reported holding SILVERBACK THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.3%.

Quarter-by-quarter ownership
Baker Brothers Advisors ownership history of SILVERBACK THERAPEUTICS INC
ValueSharesWeighting
Q3 2023$7,584,385
-43.6%
2,006,4510.0%0.04%
-43.6%
Q2 2023$13,443,222
+2.9%
2,006,4510.0%0.08%
+9.9%
Q1 2023$13,061,996
-23.7%
2,006,4510.0%0.07%
-31.1%
Q4 2022$17,115,027
+132.7%
2,006,451
+742.7%
0.10%
+221.9%
Q2 2021$7,355,000
-29.2%
238,0950.0%0.03%
-28.9%
Q1 2021$10,388,000
-5.8%
238,0950.0%0.04%
+7.1%
Q4 2020$11,033,000238,0950.04%
Other shareholders
SILVERBACK THERAPEUTICS INC shareholders Q1 2023
NameSharesValueWeighting ↓
Nextech Invest Ltd. 1,910,029$10,085,0003.26%
K2 PRINCIPAL FUND, L.P. 3,247,533$16,890,0001.94%
SECTORAL ASSET MANAGEMENT INC 1,045,234$5,519,0001.09%
Orbimed Advisors 8,740,887$46,152,0000.86%
Rubric Capital Management LP 2,695,170$14,230,0000.72%
Prosight Management, LP 196,257$1,036,0000.56%
Nantahala Capital Management 1,249,863$6,599,0000.43%
Oasis Management Co Ltd. 317,662$1,677,0000.28%
TANG CAPITAL MANAGEMENT LLC 409,463$2,162,0000.26%
APOGEM CAPITAL LLC 13,793$73,0000.07%
View complete list of SILVERBACK THERAPEUTICS INC shareholders